Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 10239927 Peptides and compositions for treatment of joint damage

Patent 10239927 was granted and assigned to Novartis on March, 2019 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity

All edits

Edits on 9 Dec, 2023
"Add patent abstract"
Golden AI profile picture
Golden AI
edited on 9 Dec, 2023
Edits made to:
Article (+239 characters)
Article

Patent abstract

The present invention provides new protease resistant polypeptides, as well as compositions and methods for treating, ameliorating or preventing conditions related to joint damage, including acute joint injury and arthritis.

Edits on 28 Apr, 2023
"Entity importer update"
Golden AI profile picture
Golden AI
edited on 28 Apr, 2023
Infobox
Is a
Patent
Patent
0
Patent Applicant
Novartis
Novartis
0
Current Assignee
Novartis
Novartis
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
102399270
Date of Patent
March 26, 2019
0
Patent Application Number
156609140
Date Filed
July 26, 2017
0
Patent Citations Received
‌
US Patent 10533042 Peptides and compositions for treatment of joint damage
0
‌
US Patent 11370820 Peptides and compositions for treatment of joint damage
0
‌
US Patent 11389541 Sustained delivery of angiopoetin-like 3 polypeptides
0
Patent Primary Examiner
‌
Elizabeth C. Kemmerer
0
Edits on 3 Apr, 2023
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 3 Apr, 2023
Edits on 26 Sep, 2022
"Entity importer update"
Golden AI profile picture
Golden AI
edited on 26 Sep, 2022
Infobox
Is a
Patent
Patent
0
Patent Applicant
Novartis
Novartis
0
Current Assignee
Novartis
Novartis
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
102399270
Date of Patent
March 26, 2019
0
Patent Application Number
156609140
Date Filed
July 26, 2017
0
Patent Citations Received
‌
US Patent 10533042 Peptides and compositions for treatment of joint damage
0
‌
US Patent 11370820 Peptides and compositions for treatment of joint damage
0
‌
US Patent 11389541 Sustained delivery of angiopoetin-like 3 polypeptides
0
Patent Primary Examiner
‌
Elizabeth C. Kemmerer
0
Edits on 23 Sep, 2022
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 23 Sep, 2022
Edits on 20 Jul, 2022
"update inverses"
Golden AI profile picture
Golden AI
edited on 20 Jul, 2022
Edits made to:
Infobox (+1 properties)
Infobox
Patent citations received
‌
US Patent 11389541 Sustained delivery of angiopoetin-like 3 polypeptides
Edits on 29 Jun, 2022
"update inverses"
Golden AI profile picture
Golden AI
edited on 29 Jun, 2022
Edits made to:
Infobox (+1 properties)
Infobox
Patent citations received
‌
US Patent 11370820 Peptides and compositions for treatment of joint damage
Edits on 31 Jan, 2022
"update inverses"
Golden AI profile picture
Golden AI
edited on 31 Jan, 2022
Edits made to:
Infobox (+1 properties)
Infobox
Patent citations received
‌
US Patent 10533042 Peptides and compositions for treatment of joint damage
Edits on 25 Jan, 2022
"Created via: Entity Importer"
Golden AI profile picture
Golden AI
created this topic on 25 Jan, 2022
Edits made to:
Infobox (+9 properties)
‌

 US Patent 10239927 Peptides and compositions for treatment of joint damage

Infobox
Is a
Patent
Patent
Patent applicant
Novartis
Novartis
Current assignee
Novartis
Novartis
Patent jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent number
10239927
Date of patent
March 26, 2019
Patent application number
15660914
Date Filed
July 26, 2017
Patent primary examiner
‌
Elizabeth C. Kemmerer

Find more entities like US Patent 10239927 Peptides and compositions for treatment of joint damage

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo